Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Polycystic Ovary Syndrome Treatment Using DLBS3233, Metformin, and Combination of Both, and Its Relation to Fertility

Trial Profile

Polycystic Ovary Syndrome Treatment Using DLBS3233, Metformin, and Combination of Both, and Its Relation to Fertility

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 29 May 2019

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs DLBS 3233 (Primary) ; Metformin
  • Indications Insulin resistance; Polycystic ovary syndrome
  • Focus Registrational; Therapeutic Use
  • Acronyms POSITIF
  • Sponsors Dexa Medica
  • Most Recent Events

    • 24 May 2019 Status changed from active, no longer recruiting to completed.
    • 24 Jan 2019 Planned End Date changed from 1 Oct 2018 to 1 Oct 2019.
    • 24 Jan 2019 Planned primary completion date changed from 1 Aug 2018 to 1 Feb 2019.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top